Dergiler / Balkan Medical Journal / 2021 / Cilt: 38 - Sayı: 3

Coronavirus Disease 2019 and Antibiotic Stewardship—Antibiotic Usagein Adult Patients: Is It Necessary? When Should It be Concerned?

Sayfa
150–155
Yayın Tarihi
2022-10-11
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

We think that a new wave of resistance will occur inevitably if wecannot perform the antibiotic stewardship properly.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Antibiotic consumption rates were quite high in number, although thebacterial coinfection rates were low in coronavirus disease 2019 pneu monia.
📊
Temel Bulgular & Veri:Generally, empirical antibiotic treatment is not recommendedfor uncomplicated coronavirus disease 2019 mild to moderate pneu monia cases.
💡
Sonuç & Katkı:We think that a new wave of resistance will occur inevitably if wecannot perform the antibiotic stewardship properly.
🔬Tür:Araştırma Makalesi
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Antibiotic consumption rates were quite high in number, although thebacterial coinfection rates were low in coronavirus disease 2019 pneu monia. Generally, empirical antibiotic treatment is not recommendedfor uncomplicated coronavirus disease 2019 mild to moderate pneu monia cases. On the other hand, antibiotic treatment and de-escalationare recommended for intubated intensive care unit patients or criticalpatients with sepsis, septic shock, or acute respiratory distress syn drome. The presentation of patients with severe coronavirus disease2019 pneumonia can direct the clinicians to use antibiotics. We believethat wait and watch strategy can be preferred in such cases without sep sis, secondary bacterial infection findings, or procalcitonin < 0.5 ng/ mL. We think that a new wave of resistance will occur inevitably if wecannot perform the antibiotic stewardship properly.

🔖

Bu Makaleye Atıf Yap

ÖNAL, U., AKALIN, H. (2022). Coronavirus Disease 2019 and Antibiotic Stewardship—Antibiotic Usagein Adult Patients: Is It Necessary? When Should It be Concerned?. Balkan Medical Journal, Cilt: 38 - Sayı: 3, 150–155. https://ajindex.com/articles/461191

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (2)

  1. CDC. Antibiotic Resistance Threats in the United States, 2019.
  2. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2019. doi: http://dx.doi. org/10.15620/cdc:82532 2. Cassini A, Högberg LD, Plachouras D, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56-66. [Crossref] 3. Paterson DL. “Collateral damage” from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis. 2004;38(suppl 4):S341-345. [Crossref] 4. Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14:13. [Crossref] 5. Rowe TA, Linder JA. Novel approaches to decrease inappropriate ambulatory antibiotic use. Expert Rev Anti Infect Ther. 2019;17(7):511-521. [Crossref] 6. Pascarella G, Strumia A, Piliego C, et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020;288(2):192-206. [Crossref] 7. Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020;39(5):405- 407. [Crossref] 8. National Institutes of Health (NIH). COVID-19 Treatment Guidelines. https://www. covid19treatmentguidelines.nih.gov/ (accessed on Nov 30, 2020). 9. WHO Interim Guidance 27 May 2020. https://www.who.int/publications/i/item/clinical-management-of-covid-19 (accessed on Nov 30, 2020). 10. Klein EY, Monteforte B, Gupta A, et al. The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis. Influenza Other Respir Viruses. 2016;10(5):394-403. [Crossref] 11. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. [Crossref] 12. Saldias Peñafiel F, Gassmann Poniachik J, Canelo López A, Díaz Patiño O. Características clínicas de la neumonía adquirida en la comunidad del adulto inmunocompetente hospitalizado según el agente causal [Features of community-acquired pneumonia in immunocompetent hospitalized adults according to the causal agent]. Rev Med Chil. 2018;146(12):1371-1383. [Crossref] 13. Karami Z, Knoop BT, Dofferhoff ASM, et al. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: